Cargando…
A chemical with proven clinical safety rescues Down-syndrome-related phenotypes in through DYRK1A inhibition
DYRK1A is important in neuronal development and function, and its excessive activity is considered a significant pathogenic factor in Down syndrome and Alzheimer's disease. Thus, inhibition of DYRK1A has been suggested to be a new strategy to modify the disease. Very few compounds, however, hav...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007978/ https://www.ncbi.nlm.nih.gov/pubmed/27483355 http://dx.doi.org/10.1242/dmm.025668 |